Clinical trials
Completed Cognitive Dysfunction trials in Japan
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2007 | 1 |
| 2011 | 1 |
| 2012 | 3 |
| 2013 | 1 |
| 2015 | 1 |
| 2018 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 12 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 3 |
| Eisai Co., Ltd. | 2 |
| Avid Radiopharmaceuticals | 1 |
| Eisai Inc. | 1 |
| Janssen Pharmaceutical K.K. | 1 |
| Japan Society of Clinical Research | 1 |
| Nara Medical University | 1 |
| National Cerebral and Cardiovascular Center, Japan | 1 |
| University of Shizuoka | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cognitive Dysfunction | 12 |
| Alzheimer Disease | 8 |
| Dementia | 6 |
| Tauopathies | 4 |
| Brain Diseases | 2 |
| Central Nervous System Diseases | 2 |
| Delirium | 2 |
| Mental Disorders | 2 |
| Nervous System Diseases | 2 |
| Neurodegenerative Diseases | 2 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.